We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHLT
11576
CALL
DELISTED
Performant Healthcare Inc
PHLT
$73K ﹤0.01%
27,700
+800
+3% +$1.99K
AKTS
11577
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$73K ﹤0.01%
19,700
+3,700
+23% +$16.4K
MPRAW
11578
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$73K ﹤0.01%
764,348
-1,001
-0.1% -$243
FATH
11579
PUT
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$73K ﹤0.01%
+940
New +$107K
USX
11580
CALL
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$73K ﹤0.01%
27,300
-5,400
-17% -$16.8K
PLXP
11581
PUT
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$73K ﹤0.01%
30,000
-18,800
-39% -$52.2K
DS
11582
PUT
DELISTED
Drive Shack Inc.
DS
$73K ﹤0.01%
53,300
-4,400
-8% -$6.27K
EOSE icon
11583
CALL
Eos Energy Enterprises
EOSE
$1.46B
$72K ﹤0.01%
59,800
+6,300
+12% +$12.9K
EVTL icon
11584
PUT
Vertical Aerospace
EVTL
$142M
$72K ﹤0.01%
2,290
-800
-26% -$48.1K
NEXA icon
11585
CALL
Nexa Resources
NEXA
$1.88B
$72K ﹤0.01%
11,900
-3,000
-20% -$25.5K
PMCB icon
11586
PharmaCyte Biotech
PMCB
$5.92M
$72K ﹤0.01%
+31,696
New +$69.3K
QRHC icon
11587
CALL
Quest Resource Holding
QRHC
$33.7M
$72K ﹤0.01%
17,700
+1,400
+9% +$7.01K
SNCR
11588
DELISTED
Synchronoss Technologies
SNCR
$72K ﹤0.01%
6,932
-2,189
-24% -$27.7K
EGLX
11589
CALL
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$72K ﹤0.01%
36,200
-30,800
-46% -$66.7K
AUID icon
11590
authID Inc
AUID
$8.83M
$71K ﹤0.01%
+4,593
New +$113K
BNED icon
11591
PUT
Barnes & Noble Education
BNED
$421M
$71K ﹤0.01%
+242
New +$70.2K
IGC icon
11592
CALL
IGC Pharma
IGC
$31.1M
$71K ﹤0.01%
133,200
+15,400
+13% +$9.71K
NGNE icon
11593
CALL
Neurogene
NGNE
$723M
$71K ﹤0.01%
3,445
-220
-6% -$5.37K
XERS icon
11594
PUT
Xeris Biopharma Holdings
XERS
$1.57B
$71K ﹤0.01%
46,300
+400
+0.9% +$844
BVC
11595
BitVentures Limited Ordinary Shares
BVC
$2.53B
$71K ﹤0.01%
+10,382
New +$71.8K
PHXM
11596
CALL
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$71K ﹤0.01%
6,470
-22,590
-78% -$280K
KLR
11597
DELISTED
Kaleyra, Inc.
KLR
$71K ﹤0.01%
9,884
+2,435
+33% +$35.7K
EPZM
11598
PUT
DELISTED
Epizyme, Inc
EPZM
$71K ﹤0.01%
48,500
+22,400
+86% +$16.5K
MACK
11599
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$71K ﹤0.01%
+11,900
New +$67.1K
AEYE icon
11600
CALL
AudioEye
AEYE
$100M
$70K ﹤0.01%
+11,600
New +$54.5K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.